Consolidated Statements Of Operations | |
Revenues | |
Operating expenses: | |
Cost of revenues | |
Research and development | |
General and administrative | 1.96M |
Total operating expenses | 2.84M |
Operating loss | -2.84M |
Write-off of debt related costs | |
Gain/(impairment charge) on investment securities | |
Foreign exchange gain/(loss) | |
Other expense | -2.78K |
Interest expense | |
Other income | 13.39K |
Income taxes | -1.68K |
Net loss | -2.84M |
Accretion to redemption value of redeemable convertible preferred stock | |
Deemed dividend resulting from beneficial conversion feature on Series C redeemable convertible preferred stock | |
Net loss applicable to common stockholders | |
Basic and diluted net loss per common share | -0.08 |
Shares used to compute basic and diluted net loss per common share |